Hepatitis C in hemodialysis centers of golestan province, northeast of Iran (2005)

Hepatitis Monthly

Volumn 8, Issue 1, 2008, Pages 61-65

  Jabbari, Ali ^a   Besharat, Sima ^a,b   Khodabakshi, Behnaz ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Deparment of Research   (Iran)

Author keywords

HCV; Hemodialysis; Incidence; Prevalence

Indexed keywords

HEPATITIS C ANTIBODY;

ABORTION; ACUPUNCTURE; ADULT; ARTICLE; BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; CIRCUMCISION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; IMMUNOBLOTTING; INCIDENCE; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NONHUMAN; ODONTOLOGY; RISK FACTOR; SURGICAL TECHNIQUE; TATTOO; TRANSPLANTATION; TREATMENT DURATION;

EID: 44949164828     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 2005; 75: 538-49.
2. Hmaied F, Ben Mamou M, Saune-Sandres K, Rostaing L, Slim A, Arrouji Z, et al. Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. J Med Virol 2006; 78: 185-91.
3. Zhou DX, Tang JW, Chu IM, Cheung JL, Tang NL, Tam JS, et al. Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong. J Med Virol 2006; 78: 574-81.
4. Perez RM, Ferraz ML, Figueiredo MS, Contado D, Koide S, Ferreira AP, et al. Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients. J Med Virol 2003; 69: 489-94.
5. Lee DS, Sung YC, Whang YS. Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol 1996; 49: 55-60.
6. Teles SA, Martins RM, Gornes SA, Gaspar AM, Araujo NM, Souza KP, et al. Hepatitis B virus transmission in Brazilian hemodialysis units: serological and molecular follow-up. J Med Virol 2002; 68: 41-9.
7. Hissar SS, Goyal A, Kumar M, Pandey C, Suneetha PV, Sood A, et al. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 2006; 78: 452-8.
8. Echevarria JM, Avellon A, Magnius LO. Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 2005; 76: 176-84.
9. Laguna-Torres VA, Perez-Bao J, Chauca G, Sovero M, Blichtein D, Chunga A, et al. Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru. J Clin Virol 2005; 34: S61-8.
10. Podlasin RB. Hepatitis C infections in dialyzed patients (in Polish). Przegl Epidemiol 2005; 59: 541-7.
11. Moreira RC, Lemos MF, Longui CA, Granato C. Hepatitis C and hemodialysis: a review. Braz J Infect Dis 2005; 9: 269-75.
12. Savey A, Simon F, Izopet J, Lepoutre A, Fabry J, Desenclos JC. A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Control Hosp Epidemiol 2005; 26: 752-60.
13. Sezer S, Tutal E, Aldemir D, Turkoglu S, Demirel OU, Afsar B, et al. Hepatitis C infection in hemodialysis patients: Protective against oxidative stress? Transplant Proc 2006; 38: 406-10.
14. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61.
15. Lopez L, Lopez P, Arago A, Rodriguez I, Lopez J, Lima E, et al. Risk factors for hepatitis B and C in multi-transfused patients in Uruguay. J Clin Virol 2005; 34: S69-74.
16. Loza Munarriz C, Depaz Dolores M, Suarez Jara M, Loza Munarriz R, Valenzuela Cordova R, Bravo Tejada J, et al. Rate of serological markers of hepatitis B and C viruses in first-time users of the hemodialysis program at Hospital Nacional Cayetano Heredia (HNCH) (in Spanish). Rev Gastroenterol Peru 2005; 25: 320-7.
17. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Fecomm Rep 1998; 47: 1-39.
18. Karaca C, Cakaloglu Y, Demir K, Ozdil S, Kaymakoglu S, Badur S, et al. Risk factors for the transmission of hepatitis C virus infection in the Turkish population. Dig Dis Sci 2006; 51: 365-9.
19. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002; 36: S93-8.
20. Carrilho FJ, Moraes CR, Pinho JR, Mello IM, Bertolini DA, Lemos MF, et al. Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology. BMC Public Health 2004; 4: 13.
21. Albuquerque AC, Coelho MR, Lopes EP, Lemos MF, Moreira RC. Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil. Mem Inst Oswaldo Cruz 2005; 100: 467-70.
22. Reddy AK, Dakshinamurty KV, Lakshmi V. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol 2006; 24: 55-7.
23. Tokars JI, Finelh L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 2004; 17: 310-9.
24. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 1993; 39: 71-80.
25. Carneiro MA, Martins RM, Teles SA Silva SA, Lopes CL, Cardoso DD, et al. Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Mem Inst Oswaldo Cruz 2001; 96: 765-9.
26. Moreira R; Pinho JR, Fares J, Oba IT, Cardoso MR, Saracem CP, et al. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol 2003; 49: 503-7.
27. Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delbi, India. Hemodial Int 2005; 9: 362-6.
28. Yanai M, Uehara Y, Takahashi S. Surveillance of infection control procedures in dialysis units in Japan: a preliminary study. Ther Apher Dial 2006; 10: 78-86.
29. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran - a multicenter study. J Med Virol 2006; 78: 569-73.
30. Alavian SM, Hosseini-Moghaddam SM, Rahnavardi M. Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features. Hep Mon 2007; 7: 153-62.
31. Izopet J, Sandres-Saune K, Kamar N, Salama G, Dubois M, Pasquier C, et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol 2005; 77: 70-6.